INTRODUCTION
Tuberculosis still remains one of the leading causes of morbidity and mortality worldwide. Controlling tuberculosis becomes more difficult by the emergence of drug-resistant Mycobacterium tuberculosis. The global surveillance program reported that resistance to anti-tuberculous drugs was found in all 35 countries and has become a global problem (1) . The overall prevalence was 12.6% for single drug resistance (range, 2.3-42.4%) and 2.2% for multidrug resistance (range, 0-22.1%). Patients infected with drug-resistant M. tuberculosis strains are less likely to be cured, particularly if they are suffering from recurrent infections, malnourished, or infected with human immunodeficiency virus (HIV) (2) . Secondline antituberculous drugs for patients infected with drug resistant M. tuberculosis are usually not bactericidal and more expensive (3) .
According to a Korean national survey of 2,486 M. tuberculosis strains isolated from patients without prior treatment, 282 (11.3%) isolates exhibited resistance to one or more drugs (4) . Among the 282 drug resistant strains, 19 (6.7%) were resistant to pyrazinamide (PZA). Interestingly, all PZA resistant strains showed resistance to other first-line drugs such as isoniazid, rifampin, and ethambutol. With this background, an accurate and rapid method to determine PZA susceptibility is crucial for the successful treatment of multidrug resistant tuberculosis in Korea.
PZA is a prodrug that is converted to bactericidal pyrazinoic acid by pyrazinamidase (PZase) produced by M. tuberculosis. Functioning exclusively in the acid environment (pH 5.0-5.5) at the site of bacterial infection (5) , PZA can kill semi-dormant (6) and probably intracellular M. tuberculosis (7) . This characteristic of PZA makes it possible to reduce total duration of treatment from 12-18 months to 6 months (8, 9) .
PZA susceptibility is usually determined by growth of M. tuberculosis on a medium containing PZA by measuring the minimum inhibitory concentration (MIC) (10) . Alternatively, PZA susceptibility has also been determined by detecting PZase activity of the cultured M. tuberculosis (11, 12) as PZase activity is lost in PZA-resistant isolates (13) . However, these conventional culture-based methods require up to 3 months and exhibit high discordance rates among laboratories (14) . A major source of discordance seems to Pyrazinamide (PZA) is one of the most important drugs for the treatment of Mycobacterium tuberculosis infection. However, the increasing frequency of PZA-resistant strains limits its effectiveness. In Korea, most PZA-resistant strains also exhibit both isoniazid and rifampin resistance making it essential to identify these resistant strains accurately and rapidly for effective treatment of mycobacterial infection. In this study, the characteristics and frequency of mutations of the pncA gene encoding pyrazinamidase were investigated in PZAresistant clinical isolates from Korea. Automated DNA sequencing was used to evaluate the usefulness of DNA-based detection of PZA resistance. Among 95 PZA-resistant clinical isolates, 92 (97%) exhibited mutations potentially affecting either the production or the activity of the enzyme. Mutations were found throughout the pncA gene including the upstream region. Single nucleotide replacement appeared to be the major mutational event (69/92), although multiple substitutions as well as insertion and deletion of nucleotides were also identified. The high frequency of pncA mutations observed in this study supports the usefulness of DNA-based detection of PZA-resistant M. tuberculosis. Having verified the scattered and diverse mutational characteristics of the pncA gene, automated DNA sequencing seems to be the best strategy for rapid detection of PZA-resistant M. tuberculosis.
originate from the low pH environment of the medium that is required for conversion of PZA to pyrazinoic acid, but is undesirable for growth of M. tuberculosis (15) .
In 1996, the gene in M. tuberculosis encoding PZase, pncA, was characterized (16) . The gene consists of 561 bp encoding a 20 kDa enzyme with 186 amino acids. Mutation of the pncA gene was suggested as the major mechanism of PZA resistance. Several subsequent studies including 20-40 PZAresistant M. tuberculosis isolates from different countries confirmed the close correlation between pncA mutation and PZA resistance (72-97%) (17) (18) (19) (20) (21) (22) (23) . These observations raised the possibility of utilizing DNA-based methods as an alternative PZA susceptibility test.
Since M. tuberculosis isolates from each country exhibit a unique DNA-fingerprint (24) , it is possible that the genetic factors controlling resistance may vary. In addition, recent reports have suggested that mutations in the pncA gene could be specific to subtypes of M. tuberculosis (23) and/or to the geographic source of the isolate (17) . In this study, the pncA gene sequence was characterized in 95 multidrug resistant, PZase negative M. tuberculosis strains isolated from Korean patients to define any possible geographic preferences for mutations in the gene, and to evaluate the utility of a DNAbased detection test for PZA-resistant M. tuberculosis isolates in Korea.
MATERIALS AND METHODS

Bacterial strains
Two strains of M. tuberculosis, H37Rv (ATCC 27294) and M. tuberculosis (ATCC 35806), were included as PZA-susceptible controls. Ninety-five PZA-resistant M. tuberculosis isolates from sputum cultures grown on Ogawa medium were obtained from the Korean Institute of Tuberculosis, which participated in the WHO-IUATLD global project (1). Resistance to PZA was determined by the PZase test using the Wayne method (25) . All PZA-resistant strains showed concomitant resistance to isoniazid, rifampin, and ethambutol.
pncA gene amplification Bacterial DNA was extracted using a kit according to the manufacturer ' s instructions (DNA PrepMate-M, Bioneer Corp, Cheongwon, Korea). The pncA gene was amplified from each M. tuberculosis isolate using primers, P1 and P6, as previously described by Scorpio et al. (22) . These primers anneal -105 bp upstream of the start codon and 55 bp downstream of the stop codon of the pncA gene, respectively. The expected size of the PCR product was 720 bp, which included the full length of the pncA gene (561 bp). An additional PCR primer set, P0 (annealing -177 bp upstream of the pncA gene) and P2 (annealing at nucleotide positions 91 to 110 bp of the pncA gene), was used for several selected isolates to study a larger segment of the upstream region in the gene. The size of the PCR product using this second PCR primer set was 287 bp in length.
PCR amplifications were carried out in a GeneAmp PCR system 9600 thermocycler (Perkin-Elmer Corp., Foster City, CA, U.S.A.). Reaction mixtures (100 L) contained 0.1-0.5 g bacterial DNA, 50 pmol of each PCR primer, 200 mol of each deoxynucleotide (dATP, dCTP, dGTP, dTTP), 2.5 units Taq DNA polymerase (Bioline, London, U.K.), 15 mM ammonium sulfate, 50 mM Tris-HCl (pH 8.8), 50 M EDTA, 1.5 mM MgCl2, 0.01% (w/v) gelatin, 10 mM betamercaptoethanol, and 10% (v/v) DMSO. The reaction mixtures were subjected to 5 min at 96℃ followed by 35 cycles of 20 sec at 96℃, 30 sec at 55℃, 60 sec at 72℃ and terminated by an additional 10 min at 72℃. Successful gene amplifications were confirmed by UV transillumination following electrophoresis on a 1% agarose gel stained with ethidium bromide in 1×TAE buffer.
DNA sequencing analysis
PCR products from each M. tuberculosis strain were purified with the PCR purification kit (Qiagen Inc., Valencia, CA, USA), according to the manufacturer' s instructions. The purified PCR product was subjected to a sequencing reaction using a BigDye Terminator Cycle Sequencing Kit with AmpliTaq DNA Polymerase, FS (PE-Applied Biosystems, CA, U.S.A.) and primers. The PCR primers were used in the sequencing reaction to obtain complete sequence information from both strands of the gene. Reaction products were analyzed on a 5% Long Ranger gel (FMC BioProducts, Rockland, Maine, U.S.A.) using an ABI Prism 377 DNA Sequencer (PE-Applied Biosystems). Sequences were analyzed using Sequence Navigator software (PE-Applied Biosystems).
RESULTS
The majority, 92 of the 95 M. tuberculosis clinical isolates (97%), exhibited mutations in the pncA gene as compared to the wild type (PZA sensitive) sequence (Table 1) . These included 73 variations at 71 dispersed sites throughout the pncA gene (Fig. 1A) . Thirteen variations were found in more than two isolates and 44 mutations were newly identified in this study. The size of the alteration varied from one to 80 bp, although most of the mutations involved only a single nucleotide (81/92; 88%). In contrast, no mutations were found in the two PZA-susceptible M. tuberculosis strains. The three PZA-resistant isolates that did not contain any alterations and the two PZA-susceptible strains, were subjected to further sequence analysis of the upstream regulatory region (up to -177), but no alterations from the wild type sequence were found.
Mutations included nucleotide substitutions (72/92 isolates), deletions (10/92), and insertions (10/92) of the pncA gene (Table 2) . Three different types of nucleotide substitutions were observed. First, six isolates carried mutations at -11 (A→G), the upstream region of the gene. This mutation was the most frequent alteration observed in this study. A unique mutation at position 169 (CAC→ GAC), defined originally in Mycobacterium bovis, was also identified in one M. tuberculosis isolate (16) . Three isolates carried substitutions at more than two sites (Table 1) . One isolate carried nucleotide substitutions at positions 29 (A to C) and 295 (T to G) resulting in amino acid changes Gln→Pro (residue 10) and Tyr→Asp (residue 99), respectively. The second isolate carried two nucleotide substitutions at positions 68 (G to T) and 69 (T to C) resulting in a single amino acid change Gly→Val at residue 23. The third isolate carried four nucleotide substitutions at positions 74 (C to A), 75 (C to A), 77 (C to G), and 83 (C to A) resulting in Ala→Glu (residue 25), Ala→Gly (residue 26), and Ala→Asp (residue 28), respectively.
Nucleotide deletions were found in 10 isolates and ranged from one to 80 bp (Table 1) . In four isolates, more than two nucleotides were deleted. Nucleotide insertions were also found in 10 isolates and all of them occurred in the 3′ -half of the gene. Nucleotide insertions ranged from one to 18 bp. In four isolates, more than two nucleotides were inserted. Deletion or insertion of nucleotides caused reading frame shift presumably resulting in either an abnormal or a prematurely truncated polypeptide.
DISCUSSION
The relationship between PZA resistance and mutation of the pncA gene has been under study ever since the gene was identified and characterized (16) . More than 200 PZA-susceptible M. tuberculosis strains failed to show any mutations of the gene including silent substitutions (18) (19) (20) 23) . In contrast, diverse mutations at various sites of the pncA gene were identified in PZA-resistant strains and the frequencies of mutation varied among studies (75-100%) (17) (18) (19) (20) (21) (22) (23) . In this study of Korean isolates, the frequency of pncA mutation appeared to be very high (97%) in PZA-resistant M. tuberculosis. This suggests that a DNA-based testing method detecting mutation in the pncA gene would be very useful as an alternative PZA susceptibility test in Korea. The method would overcome several problems encountered in conventional methods such as limitations in sensitivity, reliability, and the time requirements of the assay.
The DNA-based method, however, would still fail to detect some PZA-resistant isolates, for example, three PZAresistant isolates with defective PZase activity in this study which did not exhibit any mutations in the pncA gene. These M. tuberculosis isolates have been observed previously (17, 21) . In addition, PZA-resistant isolates retaining PZase activity, which are expected to carry a normal pncA gene, have also been reported (21, 26, 27) . This implies that other mechanisms are involved in PZA resistance. Recently, two alternative mechanisms have been proposed: active efflux of bactericidal pyrazinoic acid from the organism (28) and defects in PZA uptake of the organism (29, 30) . Defects in other genes, such as those required for PZase expression, might also be a source of PZA resistance. Based on reports described thus far, the frequency of M. tuberculosis in this category seems to be fairly low and the detection of these isolates should rely on conventional culture methods until the exact mechanisms are defined. Thus, initial screening by DNA-based method followed by conventional culture-based method for any mutation negative isolates, might be appropriate.
Several characteristics of pncA gene mutation in M. tuberculosis can be pointed out based on the data obtained in this and previously reported studies. First of all, the mutations of the gene were too diverse to address any geographic preference. The 73 types of variation including 44 never observed previously, were identified from 92 mutants in this study (Table 1) . Other studies also reported new variants. Secondly, the types of mutation are diverse: nucleotide substitutions (78%), deletions (11%), and insertions (11%) have all been observed. This characteristic was also observed in previous studies (19, (21) (22) (23) ). There appears to be a higher tendency toward nucleotide deletion and insertion in the pncA gene compared to mutations found in rpoB gene related to rifampin-resistance (31) . In addition, most of the mutations involved a single nucleotide (81/92, 88%) and majority of them was nucleotide substitution (69/81). Every mutation found thus far seems to be detrimental to the function of the PZase since all isolates were selected based on a defect in enzyme activity. This implies that the function of the enzyme is very sensitive to sequence alterations in any region of the polypeptide. In general, single amino acid substitutions have been known to be sufficient to eradicate or reduce stability of the enzyme by changes in conformation and/or alteration of hydrogen bonds or salt bridges of the polypeptide (32, 33) . Interestingly, 25% of the replacement of amino acid (15/60) involved proline. Proline has been well known to affect the conformation of the polypeptide (34) .
One of the mutants identified in this study carried a single nucleotide substitution at codon 57 (CAC→GAC) resulting in an amino acid substitution (His→Asp) ( Table 1) . This is a unique mutation specific to M. bovis, which is naturally resistant to PZA (16) . This difference has been used to discriminate M. tuberculosis from M. bovis (35, 36) . Since others have also reported PZA-resistant M. tuberculosis mutants carrying the same mutation (23), special caution should be taken in the discrimination of the two organisms using only the polymorphism at codon 57 of the pncA gene. Instead of using it alone, several other polymorphisms in other genes, such as oxyR, unique to either M. tuberculosis or M. bovis, should be tested simultaneously (35) .
Lastly, the mutations were dispersed throughout the pncA gene including the upstream region (Fig. 1) . This scattered pattern of mutation is more obvious when all reported data are combined (Fig. 1B) . To date, mutations have been found to alter 44% of the codons (81/186 codons) with no specific hot spots of variation. It should be noted that the high frequencies of mutation at some codons (e.g., codons 140 and 149) were the result of the spread of single mutant strain during any outbreak (17) . This is very unusual compared to other drug-related genes, such as rpoB and katG, where several restricted sites are involved in the conversion to drug resistance (31, 38) . This implies that the whole region encompassing the pncA may be a hot spot of mutation in the genome.
The most frequent mutation in this study (6/92, 6 .5%) involved nucleotide -11, 5′ -of the coding region, with a single nucleotide substitution (A→G). The same mutant was also identified in other studies (2, 17, 21, 23) with the highest frequency of this mutation reported in Russia (5/31, 16%) (20) . It is well known that this region upstream of the start codon (AUG) of each mRNA is a critical site for the correct positioning of the ribosome in the initiation of protein synthesis (39) . Thus, this substitution may prevent appropriate binding of the ribosome to the pncA mRNA leading to a failure in PZase protein synthesis. This hypothesis must be confirmed by further study.
Conclusively, this study confirmed the usefulness of DNAbased detection of PZA-resistant M. tuberculosis. Considering the dispersed and diverse mutational characteristics of the pncA gene, an automated DNA sequencing approach appears to be the best strategy for rapid detection of PZAresistant M. tuberculosis. In addition, the high diversity of the pncA mutations will be epidemiologically useful in tracing the outbreak or transmission of PZA-resistant M. tuberculosis strains (17, 40, 41) .
